maintenance after tirzepatide for of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide Weight Loss Maintenance Strategies
Description
Participants taking the highest dose of orforglipron (36 mg) experienced a mean weight loss of 7.3 kg , or 7.9%, compared with 1.3 kg or 1.6% in the placebo group
People with factor V Leiden are at an increased risk of deep vein thrombosis (DVT), or a pulmonary embolism (PE), but some carriers of the mutation do not develop thrombosis

Berndt J, Ooi SL, Pak SC

For others, it brings unwanted side effects or more weight loss than desired

At TrimRx, we only partner with pharmacies that meet these rigorous inspection criteria to ensure the safety and potency of the products our members receive

Why the CNS Gets Overloaded As bodybuilders grow stronger, the weights they move become heavier and more demanding
